press release – price-sensitive

PRICE-SENSITIVE | NON PRICE-SENSITIVE

  • JOINT VENTURE AGREEMENT SIGNED WITH EXOSOMICS S.P.A. FOR THE ESTABLISHMENT OF LONGEVITY BIOSCIENCE SRL

    JOINT VENTURE AGREEMENT SIGNED WITH EXOSOMICS S.P.A. FOR THE ESTABLISHMENT OF LONGEVITY BIOSCIENCE SRL
    Go to the press release

  • TURNOVER FOR THE FIRST HALF OF 2024 EQUAL TO 2.3 MILLION EUROS, AN INCREASE COMPARED TO THE SAME PERIOD IN 2023

    TURNOVER FOR THE FIRST HALF OF 2024 EQUAL TO 2.3 MILLION EUROS, AN INCREASE COMPARED TO THE SAME PERIOD IN…
    Go to the press release

  • SUBSTANTIAL CHANGE IN MATTER OF OWNERSHIP STRUCTURE

    SUBSTANTIAL CHANGE IN MATTER OF OWNERSHIP STRUCTURE
    Go to the press release

  • SUBSTANTIAL CHANGE IN MATTER OF OWNERSHIP STRUCTURE

    SUBSTANTIAL CHANGE IN MATTER OF OWNERSHIP STRUCTURE
    Go to the press release

  • TURNOVER AS OF 31 MARCH 2024 EQUAL TO 1.1 MILLION EUROS, AN INCREASE OF 26.3% COMPARED TO THE SAME PERIOD IN 2023

    TURNOVER AS OF 31 MARCH 2024 EQUAL TO 1.1 MILLION EUROS, AN INCREASE OF 26.3% COMPARED TO THE SAME PERIOD…
    Go to the press release

  • ORDINARY AND EXTRAORDINARY SHAREHOLDERS’ MEETING OF ARTERRA BIOSCIENCE S.P.A.

    ORDINARY AND EXTRAORDINARY SHAREHOLDERS' MEETING OF ARTERRA BIOSCIENCE S.P.A.
    Go to the press release

  • SECOND CALL OF SHAREHOLDERS’ MEETING

    Go to the press release

  • TURNOVER AS OF 31 DECEMBER 2023 EQUAL TO 3.3 MILLION EUROS

    TURNOVER AS OF 31 DECEMBER 2023 EQUAL TO 3.3 MILLION EUROS
    Go to the press release

  • CONCLUSION OF OWN SHARES BUY-BACK PROGRAM

    CONCLUSION OF OWN SHARES BUY-BACK PROGRAM
    Go to the press release

  • DIVIDEND DATE CORRECTION

    DIVIDEND DATE CORRECTION
    Go to the press release